Akadeum Life Sciences
PrivateLast Round
Series C
Jun 4, 2025
Total Funding Raised
$44.5M
Company Overview
Akadeum Life Sciences, Inc. is a biotechnology company that has developed and commercialized a proprietary, flotation-based separation technology called Buoyancy Activated Cell Sorting (BACS™). Founded in 2014 and based in Ann Arbor, Michigan, the company's platform uses microscopic bubbles to gently and efficiently isolate specific cells, nucleic acids, and other biological targets from samples by floating them to the surface for easy removal. This method is designed to be gentler, more scalable, and more efficient than traditional separation techniques. Akadeum's products, including kits and the Alerion™ Cell Separation System, are aimed at the life science research, diagnostics, and particularly the cell and gene therapy manufacturing markets, with a mission to advance human health by providing better tools for scientific breakthroughs.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Akadeum Life Sciences Comps
Public and private peers based on sector, stage, and business model.
Akadeum Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 4, 2025 | ||||
| Convertible Debt | May 30, 2023 | ||||
| Series B | Oct 12, 2021 | ||||
| Series A | Dec 19, 2019 | ||||
| Early Funding | Oct 9, 2015 |
Key People
Founding team and executive leadership
Akadeum Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| eLab Ventures | Early Funding |
| Detroit Innovate Fund | Early Funding |
| Arboretum Ventures | Series C, Series B |
| Beringea | Series C, Series B |
| Berkeley Catalyst Fund | Series A, Series B |
| Michigan Investment in New Technology Startups | Early Funding |
| Michigan Rise | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2026
CEO to present at Biotech Showcase 2026 on January 12, 2026.
- Oct 6, 2025
Presenting milestone updates at Cell & Gene Meeting on the Mesa.
Akadeum Life Sciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Akadeum Life Sciences's valuation, stock price, and market status.
